ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

India’s Ipca Buys Onyx Scientific

by Michael McCoy
August 15, 2011 | APPEARED IN VOLUME 89, ISSUE 33

India’s Ipca Laboratories has acquired Onyx Scientific, a U.K.-based pharmaceutical chemistry services provider. Onyx sees a strong fit between its medicinal, preclinical, and Phase I/II services and Ipca’s capabilities in Phase II and commercial-scale manufacturing. Founded in 2000, Onyx supplies custom synthesis, solid-state chemistry, scale-up, and manufacturing in batches of up to a few kilograms. Ipca, based in Mumbai, produces both active pharmaceutical ingredients and finished-dose drugs.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment